COSCIENS Biopharma Inc 20-F, filed Mar 27, 2024
COSCIENS Biopharma Inc. (CSCIF)
20-F
2024-03-27
For: 2023-12-31
View Original
Added on
April 06, 2026
About this 20-F
COSCIENS Biopharma Inc filed this 20-F on March 27, 2024, covering the fiscal year ended December 31, 2023.
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $4.5M
- down 20.2% from $5.64M a year earlier
- Net loss
- $16.55M
- compared with a net loss of $22.73M a year earlier
- Diluted EPS
- -$3.41
- compared with -$4.68 a year earlier